The State Service of Ukraine for Drugs and Drug Control has introduced a complete ban on the sale and use of a popular antibiotic based on ceftriaxone - Auroxone.

This remedy is used to treat infections of the respiratory tract, abdominal organs, kidneys and urinary tract, genitals, bones, joints, soft tissues, skin, as well as wound infections, Lyme disease and others..

According to the press service of the department, the decision to ban all the series "Auroxone" (powder for the preparation of solution for injection or infusion of 1000 mg, 1 bottle in a pack of cardboard) produced by the Indian company "Aurobindo Pharma Ltd." was taken in connection with the fact non-compliance of the medicinal product with the requirements of the quality control methods of the drug according to the indicator "Sterility".

In particular, in the course of laboratory studies of several series of medicines, the growth of bacterial flora.

In this regard, the State Forest Service obliged all business entities carrying out the storage, sale or use of the drug immediately to withdraw it from circulation by returning to the supplier or destroying.

Source: Browser.